诊断学理论与实践

诊断学理论与实践 >

2022 , Vol. 21 >Issue 02: 118 - 127

DOI: https://doi.org/10.16150/j.1671-2870.2022.02.002

规范与实施方案

上海交通大学医学院附属瑞金医院抗击新型冠状病毒定点医院公共学科工作模式

展开
  • 上海交通大学医学院附属瑞金医院,上海 200025

收稿日期: 2022-05-23

  网络出版日期: 2022-04-25

收起

Discipline working platform mode for anti-novel coronavirus Omicron in designated hospital（Ruijin Hospital, Shanghai Jiao Tong University School of Medicine）

Expand

Received date: 2022-05-23

  Online published: 2022-04-25

Fold

本文引用格式

新冠病毒定点医院公共学科工作模式撰写组 . 上海交通大学医学院附属瑞金医院抗击新型冠状病毒定点医院公共学科工作模式[J]. 诊断学理论与实践, 2022 , 21(02) : 118 -127 . DOI: 10.16150/j.1671-2870.2022.02.002

参考文献

[1] 国务院应对新型冠状病毒肺炎疫情联防联控机制综合组. 区域新型冠状病毒核酸检测组织实施指南(第三版)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7659/202203/b5aaa96dfe1b4f14b19bf2f888a10673.shtml.
[1] Comprehensive Group of the State Council on Joint Prevention and Control Mechanism for Novel Coronavirus Pneumonia. Regional guidelines for the organization and implementation of nucleic acid detection of novel coronavirus(Third Edition)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7659/202203/b5aaa96dfe1b4f14b19bf2f888a10673.shtml.
[2] Ahnach M, Zbiri S, Nejjari S, et al. C-reactive protein as an early predictor of COVID-19 severity[J]. J Med Biochem, 2020, 39(4):500-507.
[3] Zhang ZL, Hou YL, Li DT, et al. Diagnostic efficacy of anti-SARS-CoV-2 IgG/IgM test for COVID-19: A meta-analysis[J]. J Med Virol, 2021, 93(1):366-374.
[4] 钱文静, 韦欣, 陈沅, 等. 援鄂抗疫医疗队集中生活驻地的应急防控管理[J]. 中国医学装备, 2020, 17(5):206-208.
[4] Qian WJ, Wei X, Chen Y, et al. Emergency prevention and control management of centralized living quarters of anti epidemic medical teams in Hubei[J]. Chin Med Equip, 2020, 17(5):206-208.
[5] 国家卫生健康委员会办公厅. 新型冠状病毒肺炎诊疗方案 (试行第九版)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba4494583805a3d2e40093d88.shtml.
[5] General Office of the National Health Commission. Diagnosis and treatment plan for novel coronavirus pneumonia (trial version 9)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba4494583805a3d2e40093d88.shtml.
[6] Lamb YN. Nirmatrelvir plus ritonavir: first approval[J]. Drugs, 2022, 82(5):585-591.
[7] 宋美华, 张婷玉, 葛子若, 等. 静注新型冠状病毒肺炎人免疫球蛋白(pH4)治疗新型冠状病毒肺炎的疗效观察[J]. 中国药物警戒, 2021, 18(10):905-909.
[7] Song MH, Zhang TY, Ge ZR, et al. Effect of intravenous injection of human immunoglobulin(pH4) from novel coronavirus pneumonia on novel coronavirus pneumonia[J]. Chin J Phar, 2021, 18(10):905-909.
[8] Shen C, Wang Z, Zhao F, et al. Treatment of 5 critically Ⅲ patients with COVID-19 with convalescent plasma[J]. JAMA, 2020, 323(16):1582-1589.
[9] Salazar E, Christensen PA, Graviss EA, et al. Treatment of coronavirus disease 2019 patients with convalescent plasma reveals a signal of significantly decreased mortality[J]. Am J Pathol, 2020, 190(11):2290-2303.
[10] 国家卫生健康委办公厅. 静脉用药调配中心建设与管理指南(试行)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7659/202112/6fc8ae699c1f4fefb9e80a80d4f4fa55.shtml.
[10] General Office of National Health Commission. Guidelines for the construction and management of intravenous drug dispensing center(Trial)[EB/OL]. http://www.nhc.gov.cn/yzygj/s7659/202112/6fc8ae699c1f4fefb9e80a80d4f4fa55.shtml.
[11] Alquist CR, Helander L. Transfusion blood bank (recipient) testing[J]. Clin Lab Med, 2021, 41(4):599-610.
[12] Arslan O. Electronic crossmatching[J]. Transfus Med Rev, 2006, 20(1):75-79.
[13] 于布为. 新型冠状病毒肺炎的防治:来自麻醉科医师的建议[J]. 上海医学, 2020, 43(2):102-103.
[13] Yu BW. Prevention and treatment of novel coronavirus pneumonia: suggestions from anesthesiologists[J]. Shanghai Med J, 2020, 43(2):102-103.
[14] 郭莉, 高兴莲, 常后婵, 等. 疑似或确诊新型冠状病毒肺炎患者手术室感染防控专家共识[J]. 中国感染控制杂志, 2020, 19(5):385-392.
[14] Guo L, Gao XL, Chang HC, et al. Expert consensus on prevention and control of operating room infection in patients with suspected or confirmed novel coronavirus pneumonia[J]. Chin J Infect Control, 2020, 19(5):385-392.
[15] 胥娟, 杨利英, 孙惠华, 等. 新型冠状病毒肺炎疫情期间手术防护流程的改进[J]. 中华护理杂志, 2020, 55(z1):336-338.
[15] Xu J, Yang LY, Sun HH, et al. Improvement of surgical protection process during the outbreak of novel coronavirus pneumonia[J]. Chin J Nurs, 2020, 55(z1):336-338.
[16] 新型冠状病毒肺炎防控期间上海市内窥镜质控工作的指导性意见(第一版)[R].
[16] Guiding opinions on endoscopic quality control in Shanghai during the prevention and control of novel coronavirus pneumonia (First Edition)[R].
[17] 新型冠状病毒肺炎防控期间上海市内窥镜质控工作的指导性意见(第五版)[R].
[17] Guiding opinions on endoscopic quality control in Shanghai during the prevention and control of novel coronavirus pneumonia (Fifth Edition)[R].
[18] 软式内镜清洗消毒技术规范WS 507-2016[J]. 中国感染控制杂志, 2017, 16(6):587-592.
[18] Technical specification for cleaning and disinfection of flexible endoscope WS 507-2016[J]. Chin J Infect Control, 2017, 16(6):587-592.
[19] 任家材, 严丹丹, 阎红琳, 等. 新型冠状病毒感染患者病理标本处理和取材的问题及对策[J]. 临床与实验病理学杂志, 2020, 36(4):478-480.
[19] Ren JC, Yan DD, Yan HL, et al. Problems and countermeasures of pathological specimen processing and sampling in patients with novel coronavirus infection[J]. Chin J Clin Exp Pathol, 2020, 36(4):478-480.
[20] 李颖. 新冠肺炎疫情期间医疗设备科保障工作的探索与展望[J]. 中国机械, 2020(20):97-98.
[20] Li Y. Exploration and Prospect of medical equipment department support work during the COVID-19[J]. Machine Chin, 2020(20):97-98.
[21] 玖九, 彭明强, 杨帆, 等. 院内感染防控及人才队伍建设剖析[J]. 中国卫生人才, 2021(11):33-41.
[21] Mei J, Peng MQ, Yang F, et al. Analysis of nosocomial infection prevention and control and talent team construction[J]. Chin Health Human Resour, 2021(11):33-41.
[22] 胡霞, 张成, 邓波, 等. 基于结构-过程-结果模型的医院感染管理效果分析[J]. 中国医院管理, 2021, 41(8):32-35.
[22] Hu X, Zhang C, Deng B, et al. Effect analysis of nosocomial infection management based on structure process result model[J]. Chin Hosp Manage, 2021, 41(8):32-35.
Options
文章导航

/

〈 〉